Novavax, Inc. (NVAX)
USD 5.8
(6.81%)
USD 5.8
(6.81%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -487.39 Million USD | 41.02% |
| 2022 | -604.71 Million USD | 62.42% |
| 2021 | -1.68 Billion USD | -304.73% |
| 2020 | -398.22 Million USD | -200.63% |
| 2019 | -114.83 Million USD | 20.3% |
| 2018 | -162.97 Million USD | -1.29% |
| 2017 | -159.88 Million USD | 36.19% |
| 2016 | -258.49 Million USD | -71.15% |
| 2015 | -150.71 Million USD | -86.51% |
| 2014 | -78.36 Million USD | -70.4% |
| 2013 | -49.2 Million USD | -78.03% |
| 2012 | -26.8 Million USD | -40.14% |
| 2011 | -17.33 Million USD | 43.76% |
| 2010 | -35.7 Million USD | 4.42% |
| 2009 | -38.37 Million USD | -14.47% |
| 2008 | -33.74 Million USD | -6.47% |
| 2007 | -28.59 Million USD | -38.27% |
| 2006 | -18.28 Million USD | -31.4% |
| 2005 | -5.36 Million USD | 48.96% |
| 2004 | -21.02 Million USD | -119.55% |
| 2003 | -14.86 Million USD | 27.19% |
| 2002 | -20.42 Million USD | -254.14% |
| 2001 | -5.76 Million USD | 52.54% |
| 2000 | -12.14 Million USD | -189.24% |
| 1999 | -4.2 Million USD | 19.23% |
| 1998 | -4.9 Million USD | -10.64% |
| 1997 | -4.5 Million USD | 11.32% |
| 1996 | -5.2 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 173.24 Million USD | 239.39% |
| 2024 Q1 | -126.58 Million USD | 20.25% |
| 2023 FY | - USD | 41.02% |
| 2023 Q3 | -117.29 Million USD | -265.07% |
| 2023 Q2 | 71.05 Million USD | 125.44% |
| 2023 Q1 | -279.36 Million USD | -55.28% |
| 2023 Q4 | -172.77 Million USD | -47.3% |
| 2022 Q3 | -153.62 Million USD | 69.03% |
| 2022 Q4 | -179.9 Million USD | -17.11% |
| 2022 Q1 | 217.35 Million USD | 126.35% |
| 2022 FY | - USD | 62.42% |
| 2022 Q2 | -496.11 Million USD | -328.25% |
| 2021 FY | - USD | -304.73% |
| 2021 Q2 | -345.82 Million USD | -62.43% |
| 2021 Q1 | -212.9 Million USD | -16.44% |
| 2021 Q3 | -307.27 Million USD | 11.15% |
| 2021 Q4 | -824.97 Million USD | -168.48% |
| 2020 Q3 | -192.16 Million USD | -1293.37% |
| 2020 Q2 | -13.79 Million USD | 38.23% |
| 2020 FY | - USD | -200.63% |
| 2020 Q1 | -22.32 Million USD | 22.22% |
| 2020 Q4 | -182.85 Million USD | 4.84% |
| 2019 Q4 | -28.7 Million USD | 13.07% |
| 2019 FY | - USD | 20.3% |
| 2019 Q3 | -33.01 Million USD | 5.94% |
| 2019 Q1 | -38.65 Million USD | 16.9% |
| 2019 Q2 | -35.1 Million USD | 9.18% |
| 2018 Q1 | -41.75 Million USD | 12.61% |
| 2018 FY | - USD | -1.29% |
| 2018 Q3 | -40.23 Million USD | -0.1% |
| 2018 Q2 | -40.19 Million USD | 3.74% |
| 2018 Q4 | -46.51 Million USD | -15.6% |
| 2017 FY | - USD | 36.19% |
| 2017 Q2 | -39.41 Million USD | -1.84% |
| 2017 Q3 | -38.08 Million USD | 3.37% |
| 2017 Q4 | -47.78 Million USD | -25.46% |
| 2017 Q1 | -38.7 Million USD | 28.39% |
| 2016 Q3 | -61.07 Million USD | 17.91% |
| 2016 FY | - USD | -71.15% |
| 2016 Q2 | -74.39 Million USD | 1.15% |
| 2016 Q4 | -54.04 Million USD | 11.51% |
| 2016 Q1 | -75.26 Million USD | 4.61% |
| 2015 Q3 | -31.69 Million USD | -52.24% |
| 2015 Q4 | -78.9 Million USD | -148.92% |
| 2015 Q2 | -20.82 Million USD | 10.04% |
| 2015 Q1 | -23.14 Million USD | 26.9% |
| 2015 FY | - USD | -86.51% |
| 2014 Q3 | -18.64 Million USD | -10.71% |
| 2014 FY | - USD | -70.4% |
| 2014 Q2 | -16.83 Million USD | -25.71% |
| 2014 Q1 | -13.39 Million USD | -2.49% |
| 2014 Q4 | -31.66 Million USD | -69.86% |
| 2013 Q2 | -12.33 Million USD | -23.32% |
| 2013 Q1 | -10 Million USD | -11.84% |
| 2013 FY | - USD | -78.03% |
| 2013 Q4 | -13.06 Million USD | 10.25% |
| 2013 Q3 | -14.56 Million USD | -18.02% |
| 2012 FY | - USD | -40.14% |
| 2012 Q2 | -5.41 Million USD | 23.04% |
| 2012 Q3 | -6.4 Million USD | -18.37% |
| 2012 Q4 | -8.94 Million USD | -39.69% |
| 2012 Q1 | -7.03 Million USD | -84.37% |
| 2011 Q4 | -3.81 Million USD | -7.8% |
| 2011 FY | - USD | 43.76% |
| 2011 Q1 | -6.97 Million USD | -45.63% |
| 2011 Q2 | -5.48 Million USD | 21.37% |
| 2011 Q3 | -3.53 Million USD | 35.5% |
| 2010 FY | - USD | 4.42% |
| 2010 Q2 | -9.13 Million USD | 18.17% |
| 2010 Q1 | -11.15 Million USD | 20.39% |
| 2010 Q4 | -4.78 Million USD | 52.97% |
| 2010 Q3 | -10.18 Million USD | -11.52% |
| 2009 Q3 | -8.65 Million USD | -22.57% |
| 2009 FY | - USD | -14.47% |
| 2009 Q2 | -7.06 Million USD | -18.43% |
| 2009 Q4 | -14.01 Million USD | -61.89% |
| 2009 Q1 | -5.96 Million USD | 32.97% |
| 2008 Q1 | -6.99 Million USD | -112.11% |
| 2008 FY | - USD | -6.47% |
| 2008 Q4 | -8.89 Million USD | 8.46% |
| 2008 Q3 | -9.72 Million USD | -18.54% |
| 2008 Q2 | -8.2 Million USD | -17.29% |
| 2007 Q1 | -8.88 Million USD | -39.94% |
| 2007 Q4 | -3.29 Million USD | 63.0% |
| 2007 FY | - USD | -38.27% |
| 2007 Q3 | -8.9 Million USD | -3.58% |
| 2007 Q2 | -8.59 Million USD | 3.22% |
| 2006 Q1 | -4.01 Million USD | -35.64% |
| 2006 Q3 | -5.39 Million USD | 12.13% |
| 2006 Q2 | -6.13 Million USD | -52.63% |
| 2006 FY | - USD | -31.4% |
| 2006 Q4 | -6.34 Million USD | -17.79% |
| 2005 Q4 | -2.96 Million USD | -39.83% |
| 2005 Q1 | -7.39 Million USD | 18.69% |
| 2005 Q2 | -4.18 Million USD | 43.32% |
| 2005 Q3 | -2.11 Million USD | 49.42% |
| 2005 FY | - USD | 48.96% |
| 2004 FY | - USD | -119.55% |
| 2004 Q1 | -4.24 Million USD | -54.59% |
| 2004 Q2 | -6.63 Million USD | -56.12% |
| 2004 Q3 | -12.01 Million USD | -81.09% |
| 2004 Q4 | -9.08 Million USD | 24.32% |
| 2003 Q4 | -2.74 Million USD | -3.74% |
| 2003 Q3 | -2.64 Million USD | 39.09% |
| 2003 Q1 | -5.12 Million USD | -11.06% |
| 2003 Q2 | -4.34 Million USD | 15.08% |
| 2003 FY | - USD | 27.19% |
| 2002 FY | - USD | -254.14% |
| 2002 Q4 | -4.61 Million USD | 23.89% |
| 2002 Q3 | -6.33 Million USD | -22.29% |
| 2002 Q2 | -5.23 Million USD | -3.25% |
| 2002 Q1 | -5.17 Million USD | -124.52% |
| 2001 Q2 | -747 Thousand USD | 45.43% |
| 2001 Q3 | -1.51 Million USD | -102.54% |
| 2001 Q4 | -2.13 Million USD | -41.24% |
| 2001 FY | - USD | 52.54% |
| 2001 Q1 | -1.36 Million USD | 71.47% |
| 2000 Q3 | -3.27 Million USD | -20.2% |
| 2000 Q2 | -2.72 Million USD | -101.26% |
| 2000 Q1 | -1.35 Million USD | -35.3% |
| 2000 FY | - USD | -189.24% |
| 2000 Q4 | -4.79 Million USD | -46.62% |
| 1999 Q3 | -1.6 Million USD | -100.0% |
| 1999 Q2 | -800 Thousand USD | 0.0% |
| 1999 FY | - USD | 19.23% |
| 1999 Q1 | -800 Thousand USD | 50.0% |
| 1999 Q4 | -1 Million USD | 37.5% |
| 1998 Q2 | -1.3 Million USD | -44.44% |
| 1998 Q1 | -800 Thousand USD | 10.0% |
| 1998 FY | - USD | -10.64% |
| 1998 Q3 | -1.2 Million USD | 0.0% |
| 1998 Q4 | -1.6 Million USD | -23.08% |
| 1997 Q4 | -1 Million USD | 16.67% |
| 1997 Q3 | -1.1 Million USD | 14.29% |
| 1997 Q1 | -1 Million USD | 41.18% |
| 1997 Q2 | -1.4 Million USD | -40.0% |
| 1997 FY | - USD | 11.32% |
| 1996 Q2 | -1.2 Million USD | -9.09% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | -900 Thousand USD | 25.0% |
| 1996 Q1 | -1 Million USD | 0.0% |
| 1996 Q4 | -1.7 Million USD | -88.89% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -112.53 Million USD | -333.105% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2347.672% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1477.11% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -940.054% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -206.44% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -299.163% |
| Agenus Inc. | -145.92 Million USD | -234.003% |
| Fortress Biotech, Inc. | -133.64 Million USD | -264.695% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1145.821% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -220.278% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -167387.973% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -423.974% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -151734.891% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6996.535% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -88.734% |
| AlloVir, Inc. | -190.14 Million USD | -156.324% |
| Aptorum Group Limited | -9.59 Million USD | -4977.51% |
| Ardelyx, Inc. | -55.35 Million USD | -780.496% |
| Bicycle Therapeutics plc | -183.4 Million USD | -165.752% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -194.636% |
| Chimerix, Inc. | -92.97 Million USD | -424.222% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -996.819% |
| CRISPR Therapeutics AG | -202.7 Million USD | -140.448% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2013.757% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1421.097% |
| Dyadic International, Inc. | -8.22 Million USD | -5822.302% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1075.368% |
| Fortress Biotech, Inc. | -133.64 Million USD | -264.695% |
| GT Biopharma, Inc. | 5.97 Million USD | 8251.698% |
| Alkermes plc | 495.04 Million USD | 198.453% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2920.58% |
| Innoviva, Inc. | 248.96 Million USD | 295.77% |
| IO Biotech, Inc. | -91.22 Million USD | -434.255% |
| Jaguar Health, Inc. | -33.13 Million USD | -1371.1% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 579.116% |
| ContextLogic Inc. | -324 Million USD | -50.429% |
| AbCellera Biologics Inc. | -192.15 Million USD | -153.64% |
| Lantern Pharma Inc. | -15.78 Million USD | -2987.348% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5705.026% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -177.443% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -28.271% |
| MEI Pharma, Inc. | 26.38 Million USD | 1947.574% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -551.461% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1921.367% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -288.368% |
| NextCure, Inc. | -59.03 Million USD | -725.539% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -530.167% |
| ChromaDex Corporation | -3.89 Million USD | -12416.436% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -273.705% |
| Incyte Corporation | 919.42 Million USD | 153.01% |
| Opthea Limited | -200.01 Million USD | -143.672% |
| MiMedx Group, Inc. | 40.51 Million USD | 1302.927% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -749.468% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -645.644% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -17613.096% |
| Vaxcyte, Inc. | -464.88 Million USD | -4.841% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1115.892% |
| Pharming Group N.V. | 9.87 Million USD | 5034.596% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2041.244% |
| Onconetix, Inc. | -36.7 Million USD | -1227.795% |
| Acelyrin, Inc. | -381.52 Million USD | -27.748% |
| PureTech Health plc | -11.62 Million USD | -4091.881% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -520.934% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -108.735% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2611.722% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1921.367% |
| ESSA Pharma Inc. | -26.45 Million USD | -1742.315% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2770.208% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4789.547% |
| Seer, Inc. | -97.88 Million USD | -397.921% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -457.482% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 92234.216% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1582.802% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3782547.737% |
| Summit Therapeutics Inc. | 1 Million USD | 48790.31% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1359.863% |
| Senti Biosciences, Inc. | -61.33 Million USD | -694.623% |
| ImmuCell Corporation | -2.5 Million USD | -19363.858% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -210.054% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -586.233% |
| Precigen, Inc. | -89.22 Million USD | -446.242% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -758.776% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 21907.159% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -333.992% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1953.465% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -7868.386% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 9.731% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -683.623% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1401.833% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1565.835% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2317.729% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -729.036% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -182.99% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6980.041% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -135.804% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 661.432% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -851.58% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4829.652% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -105.978% |
| Aptose Biosciences Inc. | -52.26 Million USD | -832.483% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -352.362% |
| Soligenix, Inc. | -7.85 Million USD | -6106.536% |
| Century Therapeutics, Inc. | -121.2 Million USD | -302.11% |
| Kura Oncology, Inc. | -164.95 Million USD | -195.468% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -508.492% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4732.342% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -50789.647% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -11210.977% |
| Autolus Therapeutics plc | -156.77 Million USD | -210.895% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -475.723% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -606.352% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2345.019% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -157.506% |
| GRI Bio, Inc. | -10.89 Million USD | -4372.288% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -10693.197% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -297.85% |
| IGM Biosciences, Inc. | -253.35 Million USD | -92.372% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -369.583% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1178.124% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3079.133% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2995.868% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -757.402% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -355.067% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -83.231% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -151.311% |
| Verastem, Inc. | -83.16 Million USD | -486.045% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -863.755% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -208.03% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -327.202% |
| Histogen Inc. | -10.5 Million USD | -4540.484% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3313.165% |
| Surrozen, Inc. | -41.13 Million USD | -1084.97% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3191.841% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15197792.548% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -730.12% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -850.189% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2162.826% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5745.403% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -193.491% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -889.454% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1916.842% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3137.388% |
| Apollomics, Inc. | -171.74 Million USD | -183.784% |
| Amarin Corporation plc | -50.9 Million USD | -857.515% |
| Mesoblast Limited | -61.33 Million USD | -694.688% |
| Turnstone Biologics Corp. | -56.23 Million USD | -766.718% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -240.354% |
| Synaptogenix, Inc. | -8.3 Million USD | -5766.862% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3077.456% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -673.058% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10072.043% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 113700.395% |
| Exelixis, Inc. | 196.6 Million USD | 347.907% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1173.823% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -244.667% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 1.579% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4031.945% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 197251.479% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1551.834% |
| Gritstone bio, Inc. | -126.86 Million USD | -284.186% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -650.004% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12084.914% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4145.188% |
| Insmed Incorporated | -654.73 Million USD | 25.56% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -21564.483% |
| MediWound Ltd. | -4.89 Million USD | -9860.965% |
| OmniAb, Inc. | -49.73 Million USD | -880.053% |
| Alector, Inc. | -142.89 Million USD | -241.09% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -470.487% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -834.628% |
| Zai Lab Limited | -366.57 Million USD | -32.959% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -67.697% |
| Aura Biosciences, Inc. | -83.69 Million USD | -482.334% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -116.378% |
| Immunic, Inc. | -99.11 Million USD | -391.757% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -270.16% |
| Veracyte, Inc. | -49.4 Million USD | -886.44% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -6799.699% |
| FibroGen, Inc. | -261.4 Million USD | -86.45% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4274.742% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6861.394% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2504.015% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 133.627% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1817.198% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1321.835% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1967.395% |
| Galecto, Inc. | -37.51 Million USD | -1199.048% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1173.723% |
| Fortrea Holdings Inc. | 167.3 Million USD | 391.327% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -262.965% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1621.557% |
| XBiotech Inc. | -35.76 Million USD | -1262.719% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -650.004% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -646.958% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -366.603% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1798.528% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1092.625% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 5.628% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -770.013% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -869447.376% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -318.954% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2098.466% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -107.344% |
| NexImmune, Inc. | -28.16 Million USD | -1630.327% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -8720.664% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4033.131% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 110.472% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1819.463% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4061.05% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -287.291% |
| Ainos, Inc. | -8.77 Million USD | -5455.506% |
| Pluri Inc. | -20.22 Million USD | -2309.839% |
| Prothena Corporation plc | -190.1 Million USD | -156.375% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -280.185% |
| Celularity Inc. | -183.94 Million USD | -164.964% |
| Rallybio Corporation | -72.37 Million USD | -573.442% |
| Cue Biopharma, Inc. | -46.05 Million USD | -958.347% |
| MeiraGTx Holdings plc | -57.05 Million USD | -754.291% |
| Omeros Corporation | -163.61 Million USD | -197.897% |
| Humacyte, Inc. | -96.45 Million USD | -405.287% |
| Immunocore Holdings plc | -59.64 Million USD | -717.097% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2415.951% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1900.369% |
| Blueprint Medicines Corporation | -474.61 Million USD | -2.692% |
| CalciMedica, Inc. | -34.18 Million USD | -1325.575% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -565.524% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -189.336% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -93.11% |
| Pulmatrix, Inc. | -12.64 Million USD | -3754.104% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1378.463% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -450.929% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 3.738% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -381.539% |
| Cytokinetics, Incorporated | -456.68 Million USD | -6.724% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1360.432% |
| Nutriband Inc. | -5.12 Million USD | -9416.033% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1026.34% |
| Vor Biopharma Inc. | -114.37 Million USD | -326.148% |
| Roivant Sciences Ltd. | -996.51 Million USD | 51.091% |
| Evogene Ltd. | -23.2 Million USD | -2000.457% |
| ProKidney Corp. | -147.66 Million USD | -230.056% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -655.234% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -318145.63% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 13.808% |
| CorMedix Inc. | -48.88 Million USD | -896.972% |
| BioLineRx Ltd. | -57.06 Million USD | -754.156% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -336.112% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -241182.178% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1242.265% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -512.938% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -499.4% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -76.909% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1485.524% |
| MediciNova, Inc. | -9.87 Million USD | -4833.112% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -286.999% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -31751.371% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1727.568% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -116.626% |
| Biomea Fusion, Inc. | -124.62 Million USD | -291.101% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -47.542% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1770.548% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -156.064% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -111.962% |
| Absci Corporation | -95.45 Million USD | -410.586% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1523.281% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -355.003% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -108.754% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2032.531% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -134.507% |
| Allakos Inc. | -189.91 Million USD | -156.636% |
| Imunon, Inc. | -19.87 Million USD | -2351.872% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -349.24% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 549.937% |
| BioAtla, Inc. | -122.24 Million USD | -298.712% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4031.945% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2992.38% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -62.305% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1075.936% |
| XOMA Corporation | -39.36 Million USD | -1138.225% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -391.053% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -314.271% |
| aTyr Pharma, Inc. | -52.17 Million USD | -834.091% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -481.507% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -227.919% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -107.785% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3469.838% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5960.331% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2800.786% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 258380.076% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 207.842% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7529.028% |
| UroGen Pharma Ltd. | -63.83 Million USD | -663.563% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -617.647% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6610.577% |
| Orgenesis Inc. | -60.71 Million USD | -702.711% |
| Entera Bio Ltd. | -8.8 Million USD | -5436.006% |
| GH Research PLC | -41.15 Million USD | -1084.337% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1809.91% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -492.694% |
| Xencor, Inc. | -125.87 Million USD | -287.205% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -34065.764% |
| Replimune Group, Inc. | -230.19 Million USD | -111.726% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2317.895% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4354.305% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7529.028% |
| Portage Biotech Inc. | -18.19 Million USD | -2578.114% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -31751.371% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -366.027% |
| OncoCyte Corporation | -23.12 Million USD | -2007.815% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4213.048% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4154.14% |
| Purple Biotech Ltd. | -22.22 Million USD | -2092.981% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -7503.588% |
| scPharmaceuticals Inc. | -46.06 Million USD | -958.14% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2636.658% |
| HilleVax, Inc. | -132.46 Million USD | -267.936% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4483.749% |
| Tharimmune, Inc. | -9.3 Million USD | -5139.294% |
| Genprex, Inc. | -31.06 Million USD | -1469.16% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -159.905% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1454.475% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -63694.503% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 323080.173% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3095251.352% |
| Savara Inc. | -59.13 Million USD | -724.227% |
| Curis, Inc. | -45.13 Million USD | -979.754% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1487.511% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3108.382% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6702.373% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1723.109% |
| BeiGene, Ltd. | -1.12 Billion USD | 56.661% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2889.903% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -13.193% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -439.506% |
| Erasca, Inc. | -121.31 Million USD | -301.772% |
| bluebird bio, Inc. | -167.16 Million USD | -191.569% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10733.884% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 257.079% |
| DBV Technologies S.A. | -85.98 Million USD | -466.851% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -10733.884% |
| Moderna, Inc. | -3.28 Billion USD | 85.154% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1043.866% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -8529.426% |
| Molecular Templates, Inc. | 1.43 Million USD | 34183.217% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -714.325% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -49.393% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -255.528% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -928.987% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -250.555% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -136.758% |
| MacroGenics, Inc. | 2.01 Million USD | 24264.105% |
| RenovoRx, Inc. | -11.39 Million USD | -4179.104% |
| Adicet Bio, Inc. | -136.53 Million USD | -256.971% |
| Prime Medicine, Inc. | -193.75 Million USD | -151.544% |
| Aditxt, Inc. | -25.45 Million USD | -1814.489% |
| Adagene Inc. | -14.95 Million USD | -3159.963% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6567.352% |
| Quantum-Si incorporated | -91.8 Million USD | -430.903% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 168.414% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 485.426% |
| SciSparc Ltd. | -5.28 Million USD | -9127.376% |
| Vericel Corporation | 2.86 Million USD | 17117.807% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -511821.267% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2146.924% |
| Generation Bio Co. | -133.3 Million USD | -265.634% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -487.005% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -466.581% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -114.3% |
| Invivyd, Inc. | -196.61 Million USD | -147.891% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -30.265% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5154.993% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1894.911% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4638.843% |
| 2seventy bio, Inc. | -206.41 Million USD | -136.118% |
| ADMA Biologics, Inc. | 5.12 Million USD | 9619.336% |
| Clene Inc. | -43.24 Million USD | -1027.148% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2018.26% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -905.405% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1727.568% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -62.699% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1226.977% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2167.577% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 10025.961% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1400.493% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -207.688% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 28.776% |
| Evaxion Biotech A/S | -21.4 Million USD | -2177.204% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -633.855% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -123.913% |
| Trevena, Inc. | -35.28 Million USD | -1281.178% |
| Surrozen, Inc. | -41.13 Million USD | -1084.97% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -512.361% |
| Cingulate Inc. | -22.95 Million USD | -2023.516% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -6432.502% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1207.271% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5824.727% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -376.59% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -618.578% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -734.972% |
| Clearmind Medicine Inc. | -8.71 Million USD | -5495.326% |
| Kronos Bio, Inc. | -121.83 Million USD | -300.057% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -555.605% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -19863.431% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -383.392% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1351.806% |
| ImmunityBio, Inc. | -436.18 Million USD | -11.74% |
| Korro Bio, Inc. | -80.9 Million USD | -502.43% |
| Kineta, Inc. | -15.71 Million USD | -3001.629% |
| BioVie Inc. | -31.95 Million USD | -1425.467% |
| Codexis, Inc. | -49.28 Million USD | -888.962% |
| Celularity Inc. | -183.94 Million USD | -164.964% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -120.031% |
| Celcuity Inc. | -58.3 Million USD | -735.861% |
| Virax Biolabs Group Limited | -6.6 Million USD | -7274.48% |
| Cibus, Inc. | -314.58 Million USD | -54.931% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1344.846% |
| IN8bio, Inc. | -28.5 Million USD | -1609.9% |
| Kodiak Sciences Inc. | -259.02 Million USD | -88.165% |
| Annexon, Inc. | -141.57 Million USD | -244.263% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -332.855% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -659.222% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1643.481% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -111.899% |
| Eyenovia, Inc. | -24.1 Million USD | -1921.859% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1188.313% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -150329.012% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -560.384% |
| Arcellx, Inc. | -64.14 Million USD | -659.825% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -982.752% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -294.724% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1478.233% |
| Moolec Science SA | -52.07 Million USD | -835.929% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -844.444% |
| Geron Corporation | -174.78 Million USD | -178.856% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1105.903% |
| Royalty Pharma plc | 1.88 Billion USD | 125.825% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -307.541% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5127.121% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2249.914% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -193.467% |
| Humacyte, Inc. | -96.45 Million USD | -405.287% |
| Structure Therapeutics Inc. | -102.45 Million USD | -375.693% |
| 89bio, Inc. | -134.46 Million USD | -262.471% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -517.927% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 12128.381% |
| Genelux Corporation | -24.16 Million USD | -1916.925% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1341.982% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -198.164% |
| Notable Labs, Ltd. | -14.4 Million USD | -3284.653% |
| Liquidia Corporation | -70.05 Million USD | -595.765% |
| Mustang Bio, Inc. | -48.06 Million USD | -914.065% |
| Immunovant, Inc. | -269.97 Million USD | -80.53% |
| Quantum-Si incorporated | -91.8 Million USD | -430.903% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -586.6% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2424.29% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -377.777% |
| Acasti Pharma Inc. | -11.3 Million USD | -4212.804% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2090.198% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3079.133% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -131.525% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -11313.369% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2969.207% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1593.738% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1216.203% |
| PepGen Inc. | -83.58 Million USD | -483.128% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1551.945% |
| United Therapeutics Corporation | 1.38 Billion USD | 135.145% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2028.619% |
| Solid Biosciences Inc. | -93.43 Million USD | -421.641% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -10114.102% |
| Immuneering Corporation | -58.06 Million USD | -739.448% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15197792.548% |
| Silo Pharma, Inc. | -3.62 Million USD | -13340.74% |
| Belite Bio, Inc | -31.52 Million USD | -1445.847% |
| XOMA Corporation | -39.36 Million USD | -1138.225% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -622.627% |
| Bionomics Limited | -9.83 Million USD | -4854.663% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -480.33% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1308.397% |
| uniQure N.V. | -253.1 Million USD | -92.568% |
| Cassava Sciences, Inc. | -95.68 Million USD | -409.359% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6567.352% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -276.351% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1400.724% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5954.178% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1627.17% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -150329.012% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4274.742% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2965.153% |
| Altimmune, Inc. | -87.93 Million USD | -454.262% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -429.317% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1308.397% |
| Compugen Ltd. | -12.51 Million USD | -3794.136% |
| Peak Bio, Inc. | -1356.23 USD | -35937019.81% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -902.901% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2067.141% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -101.149% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1607.564% |
| Zura Bio Limited | -60.56 Million USD | -704.765% |
| PolyPid Ltd. | -20.26 Million USD | -2305.32% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3021.693% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1607.564% |
| Instil Bio, Inc. | -146.12 Million USD | -233.55% |
| argenx SE | -216.02 Million USD | -125.619% |
| Immunome, Inc. | -28.27 Million USD | -1623.993% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -905.488% |
| Verona Pharma plc | -52.46 Million USD | -828.935% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -414.276% |
| Shattuck Labs, Inc. | -87.61 Million USD | -456.286% |
| CervoMed Inc. | -2.17 Million USD | -22340.989% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -298.703% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3739.833% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -911.728% |
| Moolec Science SA | -52.07 Million USD | -835.929% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2743.585% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -273.791% |
| AnaptysBio, Inc. | -143.16 Million USD | -240.442% |
| Design Therapeutics, Inc. | -66.32 Million USD | -634.851% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -501.813% |
| NeurAxis, Inc. | -6.66 Million USD | -7213.232% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1191.099% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1232.759% |
| Achilles Therapeutics plc | -70.44 Million USD | -591.903% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -414.276% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2101.994% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 8461.114% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -19863.431% |
| Nutriband Inc. | -5.12 Million USD | -9416.033% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -344.099% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -779.257% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -864.174% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -646.649% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -800.74% |
| Palisade Bio, Inc. | -12.28 Million USD | -3868.651% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -974.114% |
| Beam Therapeutics Inc. | -156.47 Million USD | -211.485% |
| Neurogene Inc. | -52.28 Million USD | -832.162% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -257.088% |
| AEON Biopharma, Inc. | -48.36 Million USD | -907.816% |
| Sesen Bio, Inc. | -50.84 Million USD | -858.674% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -494.871% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3846.47% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -14.027% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -363.312% |
| Athira Pharma, Inc. | -116.7 Million USD | -317.633% |
| Vaccinex, Inc. | -19.74 Million USD | -2368.047% |
| HCW Biologics Inc. | -23.57 Million USD | -1967.309% |
| XOMA Corporation | -39.36 Million USD | -1138.225% |
| Nektar Therapeutics | -243.1 Million USD | -100.484% |
| Arvinas, Inc. | -394.8 Million USD | -23.452% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 258380.076% |
| Merus N.V. | -149.2 Million USD | -226.654% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -421.328% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1459.149% |
| Rezolute, Inc. | -68.42 Million USD | -612.319% |
| Clene Inc. | -43.24 Million USD | -1027.148% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3060.316% |
| BeyondSpring Inc. | -21.54 Million USD | -2162.721% |
| Synlogic, Inc. | -55.16 Million USD | -783.577% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3933.684% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4479.872% |
| Peak Bio, Inc. | -1356.23 USD | -35937019.81% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1401.278% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2822.241% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -311.567% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -42.785% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -10480.64% |
| MannKind Corporation | 15.12 Million USD | 3321.561% |
| Ikena Oncology, Inc. | -74.39 Million USD | -555.121% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3770.325% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2497.747% |
| Gossamer Bio, Inc. | -172.15 Million USD | -183.116% |
| CohBar, Inc. | -12.06 Million USD | -3939.447% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1810.659% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1523.281% |
| Legend Biotech Corporation | -477.87 Million USD | -1.992% |
| Mural Oncology plc | -192.72 Million USD | -152.901% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -327.333% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2918.779% |
| Disc Medicine, Inc. | -91.02 Million USD | -435.446% |
| Champions Oncology, Inc. | -5.05 Million USD | -9543.649% |
| REGENXBIO Inc. | -239.46 Million USD | -103.534% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4447.318% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -774.148% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1157.188% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -332.06% |
| Vaxart, Inc. | -74.72 Million USD | -552.262% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1284.304% |
| Cellectis S.A. | -98.09 Million USD | -396.855% |
| Longeveron Inc. | -20.06 Million USD | -2329.661% |
| Repare Therapeutics Inc. | -114.27 Million USD | -326.514% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -10.973% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -551.486% |
| Revolution Medicines, Inc. | -430.58 Million USD | -13.193% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -7649.881% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1483.0% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -553.425% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 10040.649% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4344.961% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 110.583% |
| Denali Therapeutics Inc. | -179.97 Million USD | -170.813% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -511821.267% |
| Veru Inc. | -89.97 Million USD | -441.691% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1713.342% |
| Cingulate Inc. | -22.95 Million USD | -2023.516% |
| Passage Bio, Inc. | -98.34 Million USD | -395.612% |
| Context Therapeutics Inc. | -25.06 Million USD | -1844.848% |
| Exicure, Inc. | -15.53 Million USD | -3036.56% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -136.524% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1218.125% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -8074.124% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -189.314% |
| Nuvalent, Inc. | -149.49 Million USD | -226.031% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5893.177% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -467.432% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1515.051% |
| OmniAb, Inc. | -49.73 Million USD | -880.053% |
| Anew Medical, Inc. | -1.3 Million USD | -37367.329% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3842.009% |
| Lipocine Inc. | -16.32 Million USD | -2885.971% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -631.048% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -555.949% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1178.124% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1149.269% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2097.133% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 10.582% |
| Ocugen, Inc. | -64.82 Million USD | -651.832% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -426.51% |
| Q32 Bio Inc. | -86.5 Million USD | -463.444% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2779.364% |
| Alumis Inc. Common Stock | -156.89 Million USD | -210.657% |
| Equillium, Inc. | -12.13 Million USD | -3915.406% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -733.544% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6066.879% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2484.119% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -943.84% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -358.31% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2624.891% |
| Dominari Holdings Inc. | -22.44 Million USD | -2071.97% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5850.935% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1817.952% |
| Bio-Techne Corporation | 326.66 Million USD | 249.203% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -26.64% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 325.238% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -271.747% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1202.103% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -222.559% |
| Nkarta, Inc. | -120.48 Million USD | -304.537% |
| BioCardia, Inc. | -11.56 Million USD | -4116.176% |
| Iterum Therapeutics plc | -34.58 Million USD | -1309.456% |